Literature DB >> 7853464

Disposition of ciprofloxacin following intravenous administration in dogs.

A R Abadía1, J J Aramayona, M J Muñoz, J M Pla Delfina, M P Saez, M A Bregante.   

Abstract

The pharmacokinetics of ciprofloxacin (CIP) following intravenous administration in dogs have been investigated. The drug was administered at three doses (2.5, 5 and 10 mg/kg body weight) and was assayed in biological fluid samples (plasma and urine) by an HPLC method. The plasma concentration-time curves were best described by a two-compartment open pharmacokinetic model. The drug was widely distributed (Vd(area) almost 3 l/kg), being distributed in the dog more rapidly than in other species (t1/2(lambda 1) 3 min approximately). The elimination half-life (t1/2 lambda 2) was 129-180 min which is similar to values obtained in other species. The unchanged drug eliminated in urine was less than 37% of the administered dose, which is less than the values obtained in humans, calves and pigs. The glomerular filtration rate and the renal clearance of CIP in the dog suggest that renal elimination probably occurs mainly by glomerular filtration. The results showed that the pharmacokinetics of CIP, as in other species, was linear in dogs in the dose range studied.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7853464     DOI: 10.1111/j.1365-2885.1994.tb00264.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  8 in total

1.  The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis).

Authors:  S P Saini; A K Srivastava
Journal:  Vet Res Commun       Date:  2001-12       Impact factor: 2.459

2.  Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs.

Authors:  M N Martinez; B Mistry; V Lukacova; K A Lentz; J E Polli; S W Hoag; T Dowling; R Kona; R M Fahmy
Journal:  AAPS J       Date:  2017-03-06       Impact factor: 4.009

Review 3.  The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.

Authors:  I Mahmood; J D Balian
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

4.  Effect of induced pyrexia on the disposition kinetics of ciprofloxacin in dogs.

Authors:  Faqir Muhammad; Masood Akhtar; M Irfan Anwar; M Javed Arshed
Journal:  Vet Res Commun       Date:  2009-09-02       Impact factor: 2.459

5.  Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

Authors:  M G Papich
Journal:  J Vet Intern Med       Date:  2017-08-03       Impact factor: 3.333

6.  Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration.

Authors:  R Raina; S Prawez; D J Dimitrova; N K Pankaj; P K Verma
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

Review 7.  Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Authors:  Nadia O Bamfo; Chelsea Hosey-Cojocari; Leslie Z Benet; Connie M Remsberg
Journal:  Pharm Res       Date:  2021-07-12       Impact factor: 4.580

8.  In vitro dissolution and in vivo bioavailability of six brands of ciprofloxacin tablets administered in rabbits and their pharmacokinetic modeling.

Authors:  Sahar Fahmy; Eman Abu-Gharbieh
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.